Abstract
Abstract β-tricalcium phosphate (β-TCP) and polycaprolactone (PCL) composites were manufactured using the lab-made 3D bioprinting system to produce 50TCP50PCL (50% β-TCP with 50% PCL) and 70TCP30PCL (70% β-TCP with 30% PCL) composite scaffolds for bone tissue engineering. The 70TCP30PCL scaffold containing the highest β-TCP content exhibited rougher morphologies and more porous than the other scaffolds ( i.e. , PCL and 50TCP50PCL). In vitro studies revealed that cell proliferation and alkaline phosphate activity were improved on the β-TCP-based composite scaffolds. Our results suggest that our 3-D printed β-TCP-containing PCL scaffolds would benefit new dental applications or regeneration therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
